JAFRON BIOMEDICAL revenue breakdown overview

JAFRON BIOMEDICAL revenue for the last year amounted to 2.68 B CNY, the most of which — 2.31 B CNY — came from its highest performing source at the moment, Disposable Hemoperfusion Device, the year earlier bringing 1.47 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JAFRON BIOMEDICAL 2.62 B CNY, and the year before that — 1.87 B CNY.